MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: Quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer

European Journal of Radiology

Volumn 76, Issue 3, 2010, Pages 359-366

  Scherr, M K ^a   Seitz, M ^b   Muller Lisse U G ^a   Ingrisch, M ^a   Reiser, M F ^a   Muller Lisse U L ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diffusion weighted imaging; Dynamic contrast enhanced MRI; Magnetic resonance imaging; Magnetic resonance spectroscopy; Perfusion; Prostate cancer; Quantitative parameters

Indexed keywords

DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST-ENHANCED MRI; PERFUSION; PROSTATE CANCERS; QUANTITATIVE PARAMETERS;

BIOPSY; BREATH CONTROLLED DEVICES; DIFFUSION; DISEASES; GADOLINIUM; MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE; TISSUE; UROLOGY;

MAGNETIC RESONANCE IMAGING;

GADOBENATE DIMEGLUMINE;

AGED; ARTICLE; BLOOD FLOW; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PLASMA VOLUME; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE ANALYSIS;

AGED; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEGLUMINE; MODELS, BIOLOGICAL; ORGANOMETALLIC COMPOUNDS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 79251628305     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.04.023     Document Type: Article

References (39)

1. M. Seitz, B. Scher, and M. Scherr Bildgebende Verfahren bei der Diagnose des Prostatakarzinoms Urologe (A) 46 2007 1435 1448
2. G. Ausa, C.C. Abboub, and M. Bollac EAU guidelines on prostate cancer Eur Urol 48 2005 546 551
3. U.G. Mueller-Lisse, and K. Miller Imaging modalities for primary diagnosis and staging of prostate cancer Urologe (A) 49 2010 190 198
4. M.R. Engelbrecht, G.J. Jager, and R.J. Laheij Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis Eur Radiol 12 2002 2294 2302
5. S.W. Heijmink, J.J. Fütterer, and T. Hambrock Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance Radiology 244 2007 184 195
6. A. Heuck, J. Scheidler, and B. Sommer MR imaging of prostate cancer Radiologe 43 2003 464 473
7. H. Hricak, P.L. Choyke, and S.C. Eberhardt Imaging prostate cancer: a multidisciplinary perspective Radiology 243 2007 28 53
8. U.G. Mueller-Lisse, and M.K. Scherr Proton MR spectroscopy of the prostate Eur J Radiol 63 2007 351 360
9. Y.J. Choi, J.K. Kim, and N. Kim Functional MR imaging of prostate cancer Radiographics 27 2007 63 77
10. D. Amsellem-Ouazana, P. Younes, and S. Conquy Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study Eur Urol 47 2005 582 586
11. C. Bhatia, S. Phongkitkarun, D. Booranapitaksonti, W. Kochakarn, and P. Chaleumsanyakorn Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results J Med Assoc Thai 90 2007 1391 1399
12. A. Prando, J. Kurhanewicz, A.P. Borges, E.M. Oliveira Jr., and E. Figueiredo Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience Radiology 236 2005 903 910 (Pubitemid 41170854)
13. J.S. Yuen, C.H. Thng, and P.H. Tan Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy J Urol 171 2004 1482 1486
14. H. Miao, H. Fukatsu, and T. Ishigaki Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging Eur J Radiol 61 2007 297 302
15. H. Kajihara, Y. Hayashida, and R. Murakami Usefulness of diffusion-weighted imaging in the localization of prostate cancer Int J Radiat Oncol Biol Phys 74 2009 399 403
16. D.L. Langer, T.H. van der Kwast, and A.J. Evans Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2 - sparse versus dense cancers Radiology 249 2008 900 908
17. P. Gibbs, M.D. Pickles, and L.W. Turnbull Diffusion imaging of the prostate at 3.0 Tesla Invest Radiol 41 2006 185 188
18. G. Manenti, M. Carlani, and S. Mancino Diffusion tensor magnetic resonance imaging of prostate cancer Invest Radiol 42 2007 412 419
19. H.J. Huisman, M.R. Engelbrecht, and J.O. Barentsz Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate J Magn Reson Imaging 13 2001 607 614
20. R. Alonzi, A.R. Padhani, and C. Allen Dynamic contrast enhanced MRI in prostate cancer Eur J Radiol 63 2007 335 350
21. J.J. Futterer, M.R. Engelbrecht, and H.J. Huisman Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers Radiology 237 2005 541 549
22. C.K. Kim, B.K. Park, and B. Kim Localization of prostate cancer using 3 T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging J Comput Assist Tomogr 30 2006 7 11
23. G.J. Jager, E.T. Ruijter, and C.A. van de Kaa Dynamic turboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results Radiology 203 1997 645 652
24. T. Franiel, L. Lüdemann, M. Taupitz, J. Rost, P. Asbach, and D. Beyersdorff Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer RöFo 181 2009 536 542
25. B. Turkbey, P.A. Pinto, and H. Mani Prostate cancer: value of multiparametric MR imaging at 3 T for detection - histopathologic correlation Radiology 255 2010 89 99
26. J. Mao, T.H. Mareci, and E.R. Andrew Experimental study of optimal selective 180° radiofrequency pulses J Magn Reson 79 1988 1 10
27. U.G. Mueller-Lisse, M.G. Swanson, and D.B. Vigneron Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging Magn Reson Med 46 2001 49 57
28. J. Scheidler, H. Hricak, and D.B. Vigneron Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study Radiology 213 1999 473 480 (Pubitemid 29510595)
29. U.G. Mueller-Lisse, D.B. Vigneron, and H. Hricak Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study Radiology 221 2001 380 390
30. S. Sourbron, A. Biffar, M. Ingrisch, Y. Fierens, and R. Luypaert PMI0.4: platform for research in medical imaging ESMRMB Antalya 2009
31. S. Sourbron, M. Dujardin, S. Makkat, and R. Luypaert Pixel-by-pixel deconvolution of bolus-tracking data: optimization and implementation Phys Med Biol 52 2007 429 447
32. G. Brix, F. Kiessling, and R. Lucht Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series Magn Reson Med 52 2004 420 429
33. S. Sourbron, M. Ingrisch, A. Siefert, M. Reiser, and K. Herrmann Quantification of cerebral blood flow, cerebral blood volume and blood-brain-barrier leakage with DCE-MRI Magn Reson Med 62 2009 205 217
34. S. Donaldson, C.M.L. West, and S.E. Davidson A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix Magn Reson Med 63 2010 691 700
35. F. Kiessling, M. Lichy, and R. Grobholz Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI. Value of two-compartment model Radiologe 43 2003 474 480
36. S.A. Bigler, R.E. Deering, and M.K. Brawer Comparison of microscopic vascularity in benign and malignant prostate tissue Hum Pathol 24 1993 220 226
37. F.M. Cavagna, F. Maggioni, and P.M. Castelli Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 1997 780 796
38. D.L. Buckley, C. Roberts, G.J. Parker, J.P. Logue, and C.E. Hutchinson Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - initial experience Radiology 233 2004 709 715
39. A.E. Wefer, H. Hricak, and D.B. Vigneron Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 2000 400 404 (Pubitemid 30481935)